Cited by 109Liver physiology and pathologyMesenchymal stem cell researchTissue Engineering and Regenerative Medicine

Liver stem cells: experimental findings and implications for human liver disease

Open access
Michalopoulos, George K., Khan, Zahida·2015·Gastroenterology

Abstract

Evidence from human histopathology and experimental studies with rodents and zebrafish has shown that hepatocytes and cholangiocytes may function as facultative stem cells for each other in conditions of impaired regeneration. The interpretation of the findings derived from these studies has generated considerable discussion and some controversies. This review examines the evidence obtained from the different experimental models and considers implications that these studies may have for human liver disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2015.08.004

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In chronic liver diseases, HHs with expression of progenitor-associated markers were documented in regenerative nodules.

    “Notably, in chronic liver diseases, HHs with expression of progenitor-associated markers were also documented in regenerative nodules (Michalopoulos and Khan, 2015; Yoon et al., 2011”

    From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Michalopoulos and Khan, 2015

    The ‘Possible Origins of LPC’ section reports hepatocyte nodules in patients with micronodular cirrhosis, supporting the chronic-disease and nodule context. It does not say that hepatocytes in those nodules expressed progenitor-associated markers; its discussion of progenitor cells in regenerative clusters concerns fulminant hepatic failure instead. Page numbers were not provided in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Cell plasticity plays an important role in liver regeneration.

    “Cell plasticity has lately been recognized to play an important role in liver regeneration (Kopp et al., 2016; Li et al., 2016; Michalopoulos and Khan, 2015”

    From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Michalopoulos and Khan, 2015

    The Conclusions describe plasticity between liver cell types, and “Possible Origins of LPC” reports that cell-type conversion can contribute to repair under severe injury or when hepatocyte replication is blocked. But that section also says that during normal liver regeneration, hepatocytes and cholangiocytes generally proliferate while retaining their identities. The unqualified claim overstates plasticity’s role across liver regeneration. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 78 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Michalopoulos, G. K., & Khan, Z.
Affiliations
University of Pittsburgh (US)
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2015-10
Volume
149
Issue
4
Pages
876-882
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2112926558
Cited by
109
References
78
Citations by year
2026: 5 · 2025: 4 · 2024: 6 · 2023: 13 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 18 · 2017: 8 · 2016: 10 · 2015: 3
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (2r01ca103958-06a1)
  • National Cancer Institute (R01CA035373, R01-CA103958)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P01DK096990)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD071834, K12HD052892)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
liver stem cells, cholangiocytes, hepatocytes, liver regeneration, liver disease, zebrafish model, rodent models
MeSH terms
Animals, Bile Ducts, Intrahepatic, Cell Differentiation, Gene Expression Regulation, Humans, Liver, Liver Diseases, Liver Regeneration, Stem Cells, Signal Transduction, Cell Lineage, Hepatocytes, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review